Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-21-069351

Director bought 150,000 shares at an average $3.66 ($549,692)

From the SEC's structured data for this filing

Trades in this filing

Shanafelt Armen · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-09 Purchase : show line 1 in the form +121,799 $3.67 $446,759 121,799 D
2021-12-10 Purchase : show line 2 in the form +13,516 $3.65 $49,333 135,315 D
2021-12-13 Purchase : show line 3 in the form +14,685 $3.65 $53,600 150,000 D
Open-market purchases · 150,000 sh · avg $3.66 · $549,692
Loading xslF345X03/doc4.xml…